Cubist Pharmaceuticals Inc (NASDAQ:CBST)
| 50.85 Real-Time Quote | +1.34 / +2.71%Today’s Change | 36.73 Today|||52-Week Range 50.93 | +20.93% Year-to-Date |
Latest CBST News | Press Releases
| Cubist Reaches New 52-Week High (CBST) 10:24am / TheStreet.com | Celgene Attains 52-Week High - Analyst Blog May 14 / Zacks.com |
| Pipeline Progress at Gilead - Analyst Blog May 16 / Zacks.com | NPS Pharma Incurs Narrower 1Q Loss - Analyst Blog May 14 / Zacks.com |
| Cempra/Toyama Ink Deal - Analyst Blog May 15 / Zacks.com | Setback for Endo Health on Opana ER - Analyst Blog May 13 / Zacks.com |
| Synergy Pharma Posts Wider Loss - Analyst Blog May 15 / Zacks.com | Earnings Beat at Warner Chilcott - Analyst Blog May 13 / Zacks.com |
| Wider-Than-Expected Loss at Athersys - Analyst Blog May 15 / Zacks.com | Narrower-than-Expected Loss at MannKind - Analyst Blog May 13 / Zacks.com |
Today’s Trading
| Previous close | 49.51 |
| Today’s open | 49.49 |
| Day’s range | 49.35 - 50.93 |
| Volume | 793,419 |
| Average volume (3 months) | 765,284 |
| Market cap | $3.2B |
| Dividend yield | -- |
Data as of 12:40pm ET, 05/20/2013
Growth & Valuation
| Earnings growth (last year) | +303.85% |
| Earnings growth (this year) | -40.12% |
| Earnings growth (next 5 years) | +20.00% |
| Revenue growth (last year) | +22.86% |
| P/E ratio | 29.4 |
| Price/Sales | 2.89 |
| Price/Book | 3.23 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ARIAARIAD Pharmaceutical... | -0.06 | -0.36% |
| PRXLPAREXEL Internationa... | -0.01 | -0.02% |
| ISISIsis Pharmaceuticals... | -0.03 | -0.15% |
| CRLCharles River Labora... | +0.03 | +0.07% |
Data as of 12:40pm ET, 05/20/2013
Financials
| Next reporting date | July 18, 2013 |
| EPS forecast (this quarter) | $0.39 |
| Annual revenue (last year) | $926.4M |
| Annual profit (last year) | $154.1M |
| Net profit margin | 16.63% |
Profile
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer & Director Michael W. Bonney |
President & Chief Operating Officer Robert J. Perez, Jr., MBA |
Corporate headquarters Lexington, Massachusetts |
Forecasts


